ATE202117T1 - Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma - Google Patents

Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma

Info

Publication number
ATE202117T1
ATE202117T1 AT94927727T AT94927727T ATE202117T1 AT E202117 T1 ATE202117 T1 AT E202117T1 AT 94927727 T AT94927727 T AT 94927727T AT 94927727 T AT94927727 T AT 94927727T AT E202117 T1 ATE202117 T1 AT E202117T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
hybridoma
angiotensin
receptor type
specific monoclonal
Prior art date
Application number
AT94927727T
Other languages
English (en)
Inventor
Gavin Paul Vinson
Stewart Barker
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10742573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE202117(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of ATE202117T1 publication Critical patent/ATE202117T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94927727T 1993-09-27 1994-09-27 Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma ATE202117T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939319877A GB9319877D0 (en) 1993-09-27 1993-09-27 Novel hybridoma & monoclonal antibodies produced thereby
PCT/GB1994/002100 WO1995009186A1 (en) 1993-09-27 1994-09-27 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas

Publications (1)

Publication Number Publication Date
ATE202117T1 true ATE202117T1 (de) 2001-06-15

Family

ID=10742573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927727T ATE202117T1 (de) 1993-09-27 1994-09-27 Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma

Country Status (9)

Country Link
US (2) US6063620A (de)
EP (1) EP0725798B1 (de)
JP (1) JP3727946B2 (de)
AT (1) ATE202117T1 (de)
AU (1) AU695074B2 (de)
CA (1) CA2170606C (de)
DE (1) DE69427484T2 (de)
GB (1) GB9319877D0 (de)
WO (1) WO1995009186A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319877D0 (en) * 1993-09-27 1993-11-10 Queen Mary Novel hybridoma & monoclonal antibodies produced thereby
GB9410639D0 (en) * 1994-05-27 1994-07-13 Queen Mary & Westfield College Method of improving fertilization
CA2314811A1 (en) * 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
GB0219524D0 (en) 2002-08-21 2002-10-02 Queen Mary & Westfield College Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
US20040093012A1 (en) 2002-10-17 2004-05-13 Cully Edward H. Embolic filter frame having looped support strut elements
US9149609B2 (en) * 2006-10-16 2015-10-06 Embolitech, Llc Catheter for removal of an organized embolic thrombus
EP2211972B1 (de) 2007-10-26 2015-12-23 Embolitech, LLC Filtersystem für intravaskulären führungsdraht für lungenembolieschutz und entfernung oder mazeration einer embolie
GB0802931D0 (en) 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
JP2011111422A (ja) * 2009-11-27 2011-06-09 Sekisui Chem Co Ltd モノクローナル抗体
WO2017019572A1 (en) 2015-07-24 2017-02-02 Ichor Vascular Inc. Embolectomy system and methods of making same
CN115838425B (zh) * 2022-08-31 2024-06-18 首都医科大学 一种靶向血管紧张素ii 1型受体细胞外第二环的抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911909A (en) * 1987-01-02 1990-03-27 E. I. Du Pont De Nemours And Company Method of controlling hypertension using monoclonal antibodies to angiotensin-II
GB9319877D0 (en) * 1993-09-27 1993-11-10 Queen Mary Novel hybridoma & monoclonal antibodies produced thereby

Also Published As

Publication number Publication date
EP0725798A1 (de) 1996-08-14
WO1995009186A1 (en) 1995-04-06
CA2170606C (en) 2005-09-20
DE69427484D1 (de) 2001-07-19
AU7703294A (en) 1995-04-18
JPH09509563A (ja) 1997-09-30
AU695074B2 (en) 1998-08-06
CA2170606A1 (en) 1995-04-06
JP3727946B2 (ja) 2005-12-21
EP0725798B1 (de) 2001-06-13
GB9319877D0 (en) 1993-11-10
US6063620A (en) 2000-05-16
US6805864B1 (en) 2004-10-19
DE69427484T2 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
DK1337629T3 (da) Dipeptidylpeptidaser
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
ATE427488T1 (de) Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
DE69427484D1 (de) Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma
ATE208820T1 (de) Humanisierte antikoerper
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
EP1881064A3 (de) Monoklonale HCV-Kern-Antikörper
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
BR0116686A (pt) Anticorpos anti-cd28 silenciados e uso dos mesmos
ATE267596T1 (de) Cyanidinzusammensetzungen und deren therapeutische und diagnostische verwendungen
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
ATE279443T1 (de) A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DK0802924T3 (da) Lægemiddel til forlænget immunsuppression og eliminering af tumorceller
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
ATE424456T1 (de) Säugetier-rezeptorproteine; ähnliche reagentien und methoden
YU13392A (sh) ANTITELA NA HUMANI RECEPTOR ZA IgE
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
NZ515382A (en) OX2 receptor homologs
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
BR0204612C1 (pt) anticorpos monoclonais antinúcleo de hcv
AR037216A1 (es) Anticuerpos monoclonales antinucleares de hcv
CY1114280T1 (el) Αντισωματα ανταγωνιστων των κυτοκινων θηλαστικων ή οι υποδοχεις τους για την αγωγη της αλλεργιας

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties